Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account
Nonrulemaking

Request that the FDA Immediate Administrative and Enforcement Action Against 503B Outsourcing Facilities Distributing Adulterated and Misbranded Ophthalmic Bevacizumab Products

🏛 Food and Drug Administration (FDA)FDA-2026-P-2257
Pharmaceutical PolicyProduct Safety & Recalls
Documents
2
Total comments
2
all analyzed
Comment status
Closed
Last activity
—
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 2Other 2